enteralogo.png
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
August 11, 2023 16:05 ET | Entera Bio Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Bigbank's Financial
Bigbank's Financial Results for July 2023
August 11, 2023 09:30 ET | BIGBANK AS
July 2023 was characterized by continued strong growth and solid profit numbers for Bigbank. In terms of loans, the portfolios of business loans, home loans and consumer loans grew in...
Bigbank AS 2023. aas
Bigbank AS 2023. aasta juuli tulemused
August 11, 2023 09:30 ET | BIGBANK AS
2023. aasta juulit iseloomustasid Bigbanki jaoks tugeva kasvu jätkumine ja soliidsed kasuminumbrid. Laenudest kasvasid üsna võrdsetes mahtudes nii ärilaenude, kodulaenude kui ka tarbimislaenude...
BiondVax LOGO.png
BiondVax Reports Second Quarter Financial Results and Provides Business Update
August 11, 2023 09:00 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative...
nxu-Logo-Black.png
Nxu Inc. to Report Second Quarter 2023 Financial Results
August 11, 2023 06:30 ET | Nxu Inc.
MESA, Ariz., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a vertically integrated technology company creating energy storage and charging solutions for the...
Mexco-Banner.jpg
Mexco Energy Corporation Reports Financial Results for First Quarter
August 10, 2023 17:29 ET | Mexco Energy Corp.
MIDLAND, TX, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) today reported net income of $465,614, or $0.21 per diluted share, for the quarter ending June 30, 2023,...
Logo.png
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 08:00 ET | Imunon, Inc.
Advances Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at...
Synlogic_Logo_Blue.png
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Osisko publie ses ré
Osisko publie ses résultats du deuxième trimestre de 2023
August 09, 2023 17:15 ET | Redevances Aurifères Osisko Ltée
MONTRÉAL, 09 août 2023 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) annonce aujourd’hui ses résultats financiers consolidés pour...
20180109-ogr_200.jpg
Osisko Reports Q2 2023 Results
August 09, 2023 17:15 ET | Osisko Gold Royalties Ltd.
MONTRÉAL, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) today announced its consolidated financial results for the second...